Newsletter October 2020
Join our Mission to End ME/CFS: Your Digital Fundraising Toolkit is Here! Passionate about our mission to end ME/CFS? Join us in our fight to fast-track critical research into Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) by starting your own digital fundraiser! Open Medicine Foundation (OMF) is excited to announce that we have […]
Medical Disclaimer
Medical Disclaimer The Open Medicine Foundation Canada Website contains text, documents, images, links to materials in document repositories and on external websites, videos, and other materials, referred to as “Content,” that were created by OMF Canada and/or provided by third parties. Any Content provided on or through this website is for informational purposes only. IT […]
Kynurenine Clinical Trial for ME / CFS
Open Medicine Foundation is excited to announce its support of an initiation of a clinical trial to understand potential disturbances in the tryptophan metabolism and to test the benefits of treating people with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) with Kynurenine. Kynurenine is naturally produced in the body, is a key metabolite in the tryptophan metabolism, […]
A message from Linda Tannenbaum regarding COVID-19
I know this is an especially stressful and uncertain time for patients and their families due to the coronavirus, and I am sending you all my strength and support. I have seen so many examples over the years of how resilient and compassionate this community is, and I trust we will come through this newest challenge […]
Stanford Working Group
Ronald W. Davis, PhD* Alain Moreau, PhD* Alan Light, PhD Alex Arron Kashi, BS Ami Mac, MD Amit Kumar Saha, PhD Amrit Shahzad, PhD Anand Ramasubramanian, PhD Anna Okumu Arun Kumar Baldomero Olivera, PhD Bela Chheda, MD Ben Wendel, PhD Brendan Robert Schmidt Bruce Schaar, PhD Christopher Armstrong, PhD* Christopher Gregg, PhD Craig Heller, PhD […]
About Ronald W. Davis, PhD
Throughout his career, Dr. Davis has conducted cutting edge, innovative, interdisciplinary research and technology development on cancer, immunology, genetics, infectious disease, novel drug development, and nanofabrication of diagnostic instruments. His emphasis has always been to increase accuracy and decrease cost. He has made significant contributions to research on numerous organisms, including bacteria, yeast, plants and […]
Stanford Research Update from Ronald W. Davis, PhD.
A Message To You From Ronald W. Davis, PhD Dr. Ron Davis, OMF Scientific Advisory Board Director and Director of the OMFCA-funded ME/CFS Collaborative Research Center at Stanford University, has a message of hope for the entire ME/CFS community. Dr. Davis and his team at Stanford are continuing to expand research and leave no stone […]
OMFCA Funded ME/CFS Collaborative Research Centre at Stanford
An End of Year Message from Ronald W. Davis, PhD, and Janet Dafoe, PhD We have accomplished so much with the amazing donations generously given to OMF and OMFCA and we are grateful. We have collected huge amounts of data in our Severely Ill Patients Study, which has yielded lots of information and hypotheses. We […]
#TripleTuesdayOMFCA Spotlight – iCPET Study
Proteomic and Metabolic Plasma iCPET Studies By Ronald G.Tompkins, MD, ScD We have received an anonymous grant of $350,000 designated for the “Proteomic and Metabolomic Plasma iCPET Studies” within the OMFCA-funded Harvard ME / CFS Collaboration at the Harvard-Affiliated Hospitals. Dr. David Systrom and his colleagues at the Brigham and Women’s Hospital have developed a […]
Experts advance ME/CFS research: Chris Armstrong interviewed on ME/CFS Alert
Dr. Christopher Armstrong Talks with Llewellyn King Llewellyn King, host of ME/CFS Alert, has just released his newest episode interviewing OMF Science Liaison Christopher Armstrong, PhD. This edition covers Dr. Armstrong’s pathway into ME/CFS research, his areas of expertise, and his role to help advance OMFCA’s ME/CFS research. This is the third in a series […]